fig1
![Rare diseases: specific challenges for sustainable accessibility of treatments for patients](https://image.oaes.cc/5e7bc15b-cb3e-4f0b-8d7e-71f13bc49860/4942.fig.1.jpg)
Figure 1. Access to the market of a drug in France: from marketing authorization to reimbursement and pricing decisions.
Figure 1. Access to the market of a drug in France: from marketing authorization to reimbursement and pricing decisions.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/